Showing posts with label what are the risks of tonsillectomy. Show all posts
Showing posts with label what are the risks of tonsillectomy. Show all posts

Monday, August 11, 2014

Weight gain triggered by tonsillectomy

A study shows that weight gain in children can be triggered by tonsillectomies used to treat sleep apnea.

Tonsillectomies are commonly done to relieve sleep apnea in children, but a new study confirms that the treatment can speed kids' weight gain -- especially if they're already overweight.
The researchers said that's a concern, because obesity is a risk factor for a range of health problems -- including, ironically, sleep apnea. But they're not advising against tonsillectomy for kids who need it.
Instead, they said, doctors and parents should be aware that a healthy diet and exercise become even more important after children have the surgery.
"You can't just treat the sleep apnea. You have to have nutrition and lifestyle counseling, too," said lead researcher Dr. Eliot Katz, a respiratory disease specialist at Boston Children's Hospital.
A pediatric sleep specialist who was not involved in the study agreed.
"Nutrition and exercise are just as important as treating the sleep apnea with a single procedure," said Dr. Sangeeta Chakravorty, who co-directs the pediatric sleep evaluation center at Children's Hospital of Pittsburgh.
Obstructive sleep apnea arises when constriction in the airways causes repeated pauses in breathing during the night. In children, the most common cause is swelling in the tonsils and adenoids -- infection-fighting tissues in the back of the throat and the nasal cavity, respectively. And surgery to remove those tissues (known technically as adenotonsillectomy) is often recommended.
Doctors have long known that after the surgery, kids can gain weight at an accelerated clip, Chakravorty said.
But the new study, reported online July 28 and in the August print issue of the journal Pediatrics, offers "certainty" that it's actually an effect of the treatment, Katz said.
That's because children in the study were randomly assigned to have surgery or to "watchful waiting" -- putting off surgery and staying with other options, such as medications to better control any nasal allergies or asthma symptoms.
Altogether, 204 children aged 5 to 9 were assigned to have surgery right away, while 192 stuck with watchful waiting. Katz's team found that over seven months, children who underwent surgery showed a quicker average weight gain, versus kids in the comparison group.
It was a small difference overall, Chakravorty said. And for children who were normal weight, there was no major effect.
"It's not making normal-weight children obese," Chakravorty noted.
But there was a clearer impact on kids who were overweight before surgery. Of those children, 52 percent had become officially obese seven months after surgery, compared with 21 percent of overweight children in the watchful-waiting group, the study found.
There are a few possible explanations for the post-surgery weight gain, according to Katz's team. Calorie-burning may dip when children are no longer laboring to breathe during sleep. And some kids may burn fewer calories during the day because they become less active after their sleep apnea improves. (Paradoxically, poor sleep often causes children to be "hyperactive," rather than drowsy, Katz explained.)
Sleep apnea itself also causes metabolic changes, Katz said. Growth hormone is released at night, and the sleep disorder can interfere with that. So the body may adapt metabolism in an effort to maintain a child's growth.
"When the sleep apnea is relieved, they're set up for rapid weight gain," Katz said.
It was once common for children with sleep apnea to be underweight and have "failure to thrive," Chakravorty noted. For those kids, rapid weight gain after tonsillectomy can be a good thing.
But these days, with childhood obesity on the rise, many kids with sleep apnea are already overweight or obese. If they rapidly put on pounds, Katz said, their sleep apnea might return in six months to a year.
"After surgery, parents are often very satisfied," Katz noted. "Their kids are sleeping better, and they may be better behaved and doing better in school. But there's this insidious issue of weight gain."
Chakravorty agreed that diet and exercise are key for children with sleep apnea -- but she said that's true regardless of the treatment approach. And, for heavy kids, weight loss alone might clear up the sleep apnea.
But if children ultimately do need surgery, parents shouldn't skip it due to worries about weight gain, according to Katz. He noted that if improved sleep apnea symptoms explain the post-surgery pounds, then other treatments -- including medication or continuous positive airway pressure devices -- could also spur excess weight gain.
"I think there are implications beyond surgical treatment," Katz said.
Read more here

Friday, February 22, 2013

Post-Surgery Codeine Puts Kids at Risk

News about use of codeine after adenotonsillectomy. JR

Post-Surgery Codeine Puts Kids at Risk

Is Post-Surgery Codeine a Risk for Kids? - (JPG)
Children are often prescribed codeine for pain relief after surgery to remove their tonsils or adenoids to treat chronic tonsillitis or sleep apnea, a condition in which breathing problems make it hard for them to sleep soundly.
However, some children have died after being given codeine in amounts that are within the recommended dose range.
The Food and Drug Administration (FDA) is taking steps to warn about the use of codeine to relieve children's pain after surgery to remove their tonsils or adenoids.
In August 2012, FDA warned the public that this danger exists for children who are "ultra-rapid metabolizers" of codeine, meaning that their liver converts codeine to morphine in higher than normal amounts.
Since then, FDA has conducted a comprehensive safety review of codeine use in children. A search of FDA's Adverse Event Reporting System (AERS) database from 1969 to May 1, 2012 identified 10 deaths and three overdoses associated with codeine. Many of these children were recovering from a surgery to remove their tonsils or adenoids.
A new boxed warning—FDA's strongest warning—will be added to the drug label of codeine-containing products about the risk of codeine to manage pain in children after a tonsillectomy and/or adenoidectomy. (The drug label is the written material that accompanies a prescription medication.)
FDA strongly recommends against the use of codeine to manage pain in children after a tonsillectomy and/or adenoidectomy. The agency asks health care professionals to use an alternate pain reliever.
In addition, parents and caregivers need to be aware of the risks of codeine treatment after tonsillectomy or adenoidectomy and should ask for a different pain medicine if their child is prescribed codeine in that setting

The Problem 

Codeine is an opioid pain reliever—a narcotic medication—used to treat mild to moderate pain. It is also used to reduce coughing, usually in combination with other medications. Codeine is available by prescription either alone or in combination with acetaminophen or aspirin, and in some cough and cold medications.
Codeine is converted to morphine in the liver by an enzyme. Some people have genetic variations that make this enzyme over-active, causing codeine to be converted to morphine faster and more completely than in other people. These ultra-rapid metabolizers are more likely to have higher than normal amounts of morphine in their blood after taking codeine. High levels of morphine can result in breathing difficulty, which may be fatal.
From one to seven in every 100 people are ultra-rapid metabolizers, but they are more common among some ethnic groups. Twenty-nine percent of North African and Ethiopian populations are ultra-rapid metabolizers, and about 6 percent of African American, Caucasian and Greek populations are also affected.
The only way to know if someone is an ultra-rapid metabolizer is to do a genetic test. There are FDA-cleared tests to check for ultra-rapid metabolism.
The cases occurred in children who showed evidence of being ultra-rapid metabolizers. The children ranged in age from 21 months to 9 years old. All of the children received doses of codeine that were within the typical dose range, meaning that they were not given extra amounts of the medication.
In these cases, the signs of morphine overdose developed within one to two days after the children started taking codeine.

Signs of Trouble 

The new changes to the codeine label warn health professionals about the use of codeine after tonsillectomy and/or adenoidectormy. FDA says that codeine should only be prescribed to children with other types of pain if the benefits are expected to outweigh the risks.
The agency warns that when prescribed to treat pain, codeine should not be given on a schedule, but only when the child needs relief from pain. Children should never receive more than six doses in a day.
Parents and caregivers should watch children receiving codeine for pain closely for signs of morphine overdose. There are a number of symptoms to watch for, says Bob Rappaport, M.D., director of the Division of Anesthesia, Analgesia and Addiction Products (DAAAP) in FDA's Center for Drug Evaluation and Research. If your child shows these signs, stop giving the codeine and seek medical attention immediately by taking your child to the emergency room or calling 911:
  • Unusual sleepiness, such as being difficult to wake up
  • Disorientation or confusion
  • Labored or noisy breathing, such as breathing shallowly with a "sighing" pattern of breathing or deep breaths separated by abnormally long pauses
  • Blueness on the lips or around the mouth

FDA Drug Safety Communication: Safety review update of codeine use in children; new Boxed Warning and Contraindication on use after tonsillectomy and/or adenoidectomy


FDA Drug Safety Communication: Safety review update of codeine use in children; new Boxed Warning and Contraindication on use after tonsillectomy and/or adenoidectomy


This update is in follow-up to the FDA Drug Safety Communication: Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death issued on 8/15/2012.
 View and print full DSC - DSC Update on Codeine 02-2013 [PDF -116KB] 
Safety Announcement
[2-20-2013] The U.S. Food and Drug Administration (FDA) is updating the public about new actions being taken to address a known safety concern with codeine use in certain children after tonsillectomy and/or adenoidectomy (surgery to remove the tonsils and/or adenoids). Deaths have occurred post-operatively in children with obstructive sleep apnea who received codeine for pain relief following a tonsillectomy and/or adenoidectomy. Codeine is converted to morphine by the liver.  These children had evidence of being ultra-rapid metabolizers of codeine, which is an inherited (genetic) ability that causes the liver to convert codeine into life-threatening or fatal amounts of morphine in the body.
A new Boxed Warning, FDA’s strongest warning, will be added to the drug label  of codeine-containing products about the risk of codeine in post-operative pain management in children following tonsillectomy and/or adenoidectomy. A Contraindication, which is a formal means for FDA to make a strong recommendation against use of a drug in certain patients, will be added to restrict codeine from being used in this setting. The Warnings/Precautions, Pediatric Use, and Patient CounselingInformation sections of the drug label will also be updated.
In August 2012, FDA announced it was reviewing the safety of codeine due to cases of deaths and serious adverse events in children who took the drug after a tonsillectomy and/or adenoidectomy and had evidence of being ultra-rapid metabolizers of codeine. FDA conducted a comprehensive safety review to identify additional cases of overdose or death in children taking codeine and to determine if these adverse events occurred in any other treatment settings. Many of the cases of serious adverse events or death occurred in children with obstructive sleep apnea who received codeine after a tonsillectomy and/or adenoidectomy (see Data Summary). Since these children already had underlying breathing problems, they may have been particularly sensitive to the breathing difficulties that can result when codeine is converted in the body to high levels of morphine. However, this contraindication applies to all children undergoing tonsillectomy and/or adenoidectomy because it is not easy to determine which children might be ultra-rapid metabolizers of codeine.
Health care professionals should prescribe an alternate analgesic for post-operative pain control in children who are undergoing tonsillectomy and/or adenoidectomy. Codeine should not be used for pain in children following these procedures.
For management of other types of pain in children, codeine should only be used if the benefits are anticipated to outweigh the risks.